Agile Therapeutics Stock Analysis
Technical stock analysis for 18 January 2019
Agile Therapeutics gained 14.23% in the last trading day, rising from $0.78 to $0.89 The price has fallen in 5 of the last 10 days , but is still up by 14.23% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 610 581 more shares were traded than the day before. In total, 691 843 shares bought and sold for approximately $616 432.00.
Close price at the end of the last trading day (Friday, 18th Jan 2019) of the AGRX stock was $0.89. This is 14.23% more than the trading day before Thursday, 17th Jan 2019.
During day the stock fluctuated 14.74% from a day low at $0.78 to a day high of $0.90.
30 day high of the AGRX stock price was $0.90 and low was $0.55.
90 day high was $1.17 and low was $0.53.
52 week high for the Agile Therapeutics - $3.92 and low - $0.23.
Agile Therapeutics has broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction there will be support on the roof on the current trend broken, which is $0.89, a level that may pose a second chance to hit a runner. According to fan-theory $1.26 will be the next possible trendtop level and thereby pose a resistance level which may not be broken on the first attempt.
Agile Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $0.79 and $0.74. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday December 31, 2018, which indicates further gains until a new top pivot has been found. Agile Therapeutics has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Relative Strength Index (RSI)
The stock holds a RSI14 at 81 and is currently being overbought on RSI. This does not have to be a sales signal as many stocks may go both long and hard while being overbought on the RSI. It is therefore important to evaluate the history of the share as it may tell you something about the RSI-sensitiveness.
Support & Resistance
Agile Therapeutics finds support from accumulated volume at $0.86.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.12 between high and low, or 14.74%. For the last week, the stock has had a daily average volatility of 6.93%.
The stock is extremely overbought on RSI14 (81). Normally this will pose a good selling opportunity, but since the stock has broken the trend up the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.
Our recommended stoploss: $0.85 (-4.82%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 81 and this increases the risk substantially. There is a buy signal from pivot bottom found 13 days ago.)
Very Low Low Medium High Very High
Agile Therapeutics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.
|AGRX $0.89 $0.11(14.23%)|
AGRX is up $0.11 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AGRX based on the 1-3 month system that more than doubles the S&P 500.
Click here – the AGRX analysis is free »